Skip to content
All Sections
Subscribe Now
66°F
Tuesday, July 23rd 2024
e-Edition
Home Page
Close Menu
News
News
Crime and Public Safety
Investigative Reporting
Politics
Health
Environment
Business
Best Reviews
Housing
Jobs
Local News
Local News
Long Beach
Los Angeles
Los Angeles County
Sports
Sports
High School Sports
Chargers
Rams
Lakers
Clippers
Dodgers
Angels
College Sports
UCLA Sports
USC Sports
Long Beach State sports
Kings
Ducks
Olympics
Boxing/MMA
Soccer
Horse Racing
Things To Do
Things To Do
Restaurants Food and Drink
Movies
Music + Concerts
Theater
TV and Streaming
Home + Garden
Travel
Amusement Parks
Comics
Puzzles
Events
Obituaries
Obituaries
News Obituaries
Place an Obituary
Opinion
Opinion
Editorials
Opinion Columns
Commentary
Letters to the Editor
Editorial Board
Endorsements
The Grunion
The Grunion
News
Education
Sports
Things to Do
Opinion
E-Edition
Advertising
Contact Us
SCNG Premium
The T.E.A.
Subscribe
Press-Telegram Store
Log In
Logout
Close Menu
Get the latest news delivered daily!
Sign Up
Subscribe
Log In
Account Settings
Contact Us
Log Out
Spoof a user
Get the latest news delivered daily!
Sign Up
Subscribe
Log In
Search
Press Telegram
66°F
Tuesday, July 23rd 2024
e-Edition
News
Local News
Sports
Things to Do
Obituaries
Opinion
The T.E.A.
Trending:
Biden drops out of race
Project 2025's impact in CA
Homeless pet food pantry opens
SpaceX moving to Texas
LB Burger Week ð
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Anixa Biosciences Inc
(NQ:
ANIX
)
3.130
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
990,684
Open
3.130
Bid (Size)
3.090 (1)
Ask (Size)
3.150 (20)
Prev. Close
3.130
Today's Range
3.130 - 3.130
52wk Range
2.145 - 5.130
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
EXCLUSIVE: FDA Approves Anixa Biosciences' Individual Patient Trial Application For Ovarian Cancer CAR-T Therapy
Today 7:45 EDT
FDA Approves Anixa Biosciences' Ovarian Cancer CAR-T Therapy for Individual Patient Trial. Moffit Cancer Center receives approval for a second dose in an ongoing Phase I trial showing early promising...
Via
Benzinga
Exposures
Product Safety
EXCLUSIVE: Anixa Biosciences Finds Stock Undervalued, Launches $5M Stock Buyback Program
July 15, 2024
Anixa Biosciences announces $5 million share repurchase program due to undervalued stock. Partnership with Cleveland Clinic for cancer vaccines.
Via
Benzinga
Performance
YTD
-20.36%
-20.36%
1 Month
+25.20%
+25.20%
3 Month
+3.99%
+3.99%
6 Month
-35.46%
-35.46%
1 Year
-16.53%
-16.53%
More News
Read More
ANIX Stock Earnings: Anixa Biosciences Beats EPS for Q2 2024
June 04, 2024
Via
InvestorPlace
7 Penny Biotech Stocks to Triple Your Investment
May 28, 2024
Via
InvestorPlace
Anixa Biosciences, Inc. (NASDAQ: ANIX) Featured in Coverage of the EF Hutton Annual Global Conference
May 16, 2024
Via
Investor Brand Network
Recap: Anixa Biosciences Q1 Earnings
March 12, 2024
Via
Benzinga
6 Analysts Have This to Say About Anixa Biosciences
June 19, 2023
Via
Benzinga
The Latest Analyst Ratings for Anixa Biosciences
May 23, 2023
Via
Benzinga
Sidoti Events, LLC's Virtual May Micro-Cap Conference
May 07, 2024
Via
ACCESSWIRE
Anixa Biosciences (NASDAQ:ANIX) Gains Attention for Its Innovative Cancer Therapies Amid Biopharma Sector Growth
March 20, 2024
Via
AB Newswire
Sidoti Events, LLC's Virtual January Micro-Cap Conference
January 15, 2024
Via
ACCESSWIRE
Anixa Biosciences, A New Type Of Biotech Company: Could It Disrupt The Cancer Landscape?
December 20, 2023
Via
Benzinga
Expert Ratings for Anixa Biosciences
April 18, 2023
Via
Benzinga
3 Biotech Stocks to Turn $5,000 Into $1 Million: December 2023
December 11, 2023
Via
InvestorPlace
Anixa Biosciences Reveals Updated Data From Breast Cancer Vaccine Trial, Says 'Exceeded Expectations'
December 07, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 07, 2023
Via
Benzinga
The 3 Most Undervalued Cheap Stocks to Buy in September 2023
September 11, 2023
Via
InvestorPlace
Could Anixa Biosciences (NASDAQ:ANIX) Be Developing The Vaccine To End One Of The Deadliest Types Of Breast Cancer?
August 10, 2023
Via
ACCESSWIRE
Could Anixa Biosciences (NASDAQ: ANIX) Be Developing The Vaccine To End One Of The Deadliest Types Of Breast Cancer?
August 09, 2023
Via
Benzinga
Anixa Biosciences And 2 Other Penny Stocks Insiders Are Aggressively Buying
July 24, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
February 23, 2023
Via
Benzinga
Appreciating The Passing Of A Titan & Incorporating Alternative Data Signals
December 27, 2022
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For December 23, 2022
December 23, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
December 09, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
October 10, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Close